tiprankstipranks
BeiGene reports Q1 GAAP EPS 1c, consensus (74c)
PremiumThe FlyBeiGene reports Q1 GAAP EPS 1c, consensus (74c)
10d ago
BeiGene sees FY25 revenue $4.9B-$5.3B, consensus $5.09B
Premium
The Fly
BeiGene sees FY25 revenue $4.9B-$5.3B, consensus $5.09B
10d ago
BeiGene says USPTO invalidates Pharmacyclics’ ‘803 patent
Premium
The Fly
BeiGene says USPTO invalidates Pharmacyclics’ ‘803 patent
18d ago
BeiGene receives positive CHMP opinion for Tevimbra
PremiumThe FlyBeiGene receives positive CHMP opinion for Tevimbra
2M ago
BeiGene price target raised to $259 from $207 at Bernstein
Premium
The Fly
BeiGene price target raised to $259 from $207 at Bernstein
2M ago
BeiGene’s Strong Market Position and Growth Potential: A Buy Rating by Reni Benjamin
Premium
Ratings
BeiGene’s Strong Market Position and Growth Potential: A Buy Rating by Reni Benjamin
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100